Table 1.
Characteristics of patients with endometrium samples
| Variable |
Patients with live birth N = 24 |
Patients without live birth N = 15 |
P-value |
|---|---|---|---|
| Age, y | 32.5(28.3,37.0) | 32(29,35) | P = 0.028, t = 0.4 |
| Body mass index, kg/m2 | 23.1(21.2,23.4) | 22.9(20.7,23.9) | P = 0.4, t = -0.09 |
| Fertility history | |||
| Duration of infertility, year | 3(2,4) | 2(1,3) | P = 0.2, t = 0.25 |
| Primary infertility, no. (%) | 16(66.7) | 8(53.3) | P = 0.41, χ2 = 0.69 |
| Indications for IVF, no. (%) | |||
| Endometriosis | 1(4.1) | 1(6.7) | P = 0.73, χ2 = 0.12 |
| Tubal factor | 12(50) | 7(46.7) | P = 0.84, χ2 = 0.04 |
| Male factor | 18(75) | 11(73.3) | P = 0.91, χ2 = 0.01 |
| Ovulatory factor | 7(33.3) | 2(13.3) | P = 0.02, χ2 = 8.41 |
| Number of failed embryo transfer cycle, median (range) | 0.63(0–3) | 1.28(0–8) | P = 0.03, t = -1.04 |
| Repeated implantation failure, no. (%) | 2(40) | 3(60) | P = 0.29, χ2 = 1.12 |
| Hormone tests and Ultrasound | |||
| AMH, ng/ml | 3.85(1.83,6.02) | 4.31(2.47–7.5) | P = 0.33, t = -0.72 |
| Antral Follicle Counting | 14(7.5,19.8) | 11(10,17) | P = 0.67, t = -0.12 |
| Ovarian sensitivity index (OSI) | 0.79(0.51, 0.90) | 0.80(0.48, 1.01) | P = 0.82, t = -0.54 |
| COH protocol | |||
| GnRH agonists, no. (%) | 15(65.2) | 8(34.8) | P = 4 × 10–3, χ2 = 10.98 |
| GnRH antagonists, no. (%) | 7(29.2) | 7(46.7) | |
| CC Mild stimulation, no. (%) | 2(100) | 0(0) | |
| Duration of COH, (day) | 10(9.25,12) | 11(9, 12) | P = 0.46, t = -0.20 |
| Total dose of FSH/hMG (UI) | 2306.25(1968.75, 2925) | 2700(1762.5,3600) | P = 0.02, t = -0.94 |
| No. of oocytes retrieved | 13.5(8, 16.75) | 15(11, 17) | P = 0.13, t = -0.56 |
| Endometrial thickness before ET | 9.5(9,11.3) | 8(7.8,10.5) | P = 0.22, t = 1.53 |
| Regiment of endometrial preparation | |||
| Natural cycle no. (%) | 15(62.5) | 9(60) | P = 0.88, χ2 = 0.02 |
| Artificial cycle no. (%) | 9(37.5) | 6(40) | |
| Luteal-phase support | |||
| Oral dydrogesterone protocol | 15(62.5) | 9(60) | P = 0.88, χ2 = 0.02 |
| Progesterone injection protocol | 9(37.5) | 6(40) | |
| Number of embryos transferred | |||
| One embryo | 4(16.7) | 5(33.3) | P = 0.27, χ2 = 1.45 |
| Two embryos | 20(83.3) | 10(66.7) | |
| Type of embryo transferred | |||
| Cleavage transfer, no. (%) | 13(54.2) | 4(26.7) | P = 0.09, χ2 = 2.84 |
| Blastocyst transfer, no. (%) | 11(45.8) | 11(73.3) | |
AMH Anti-Mullerian Hormone, COH Controlled ovarian stimulation, ET Embryo transfer